# MoonLake Immunotherapeutics: Form 8-K, filed Oct 22, 2020

- Company: [MoonLake Immunotherapeutics](/companies/mltx.md) (CIK 1821586)
- Form: 8-K
- Filed: 2020-10-22
- Accepted by EDGAR: Oct 22, 2020, 17:06 ET
- Period: 2020-10-19
- Accession: 0001213900-20-032858
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1821586/000121390020032858/ea128762-8k_helixacquisition.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1821586/000121390020032858/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1821586/000121390020032858/ea128762-8k_helixacquisition.htm

Filed Oct 22, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-032858. Last ingested by Listed: Nov 4, 2026, 07:34 ET. No prices; not investment advice.
